Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Casdin Capital
company
About
Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry.
- 1 - 10
Highlights
Details
- Industries
- Biotechnology,Financial Services,Life Science
- Founded date
- Jan 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- MVC
Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry. It manages a long-short equity fund and makes investments in early-stage to late-stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets under management.
Investments
Number of Investments
Number of Lead Investments
34
8
Casdin Capital has made 34 investments. Their most recent investment was on
Mar 17, 2022, when Deepcell raised $73M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Mar 17, 2022
Deepcell
|
Series B | $73M | Artificial Intelligence | — |
|
Nov 29, 2021
Lunit
|
Series Unknown | $61M | Artificial Intelligence | — |
|
Oct 7, 2021
Science 37
|
Post-IPO Equity | $200M | Biotechnology | — |
|
Sep 1, 2021
SomaLogic
|
Post-IPO Equity | $375M | Biotechnology | — |
|
Jul 20, 2021
TMRW Life Sciences
|
Series C | $105M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
